Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Alexa Fluor 594-conjugated Antibody, R&D Systems™
Manufacturer: R&D Systems
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | FAB9576T100-Each-of-1 | In Stock | ₹ 44,722.50 |
FAB9576T100 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,722.50
GST (18%): ₹ 8,050.05
Total Price: ₹ 52,772.55
Antigen
CD30/TNFRSF8
Classification
Monoclonal
Conjugate
Alexa Fluor 594
Formulation
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
Host Species
Human
Purification Method
Protein A or G purified from cell culture supernatant
Primary or Secondary
Primary
Test Specificity
Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only.
Content And Storage
Protect from light.Do not freeze.12 months from date of receipt, 2 to 8 degreesC as supplied.
Isotype
IgG1
Applications
Flow Cytometry
Clone
Hu8
Dilution
Flow Cytometry 0.25-1 ug/10^6 cells
Gene Alias
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Immunogen
Human CD30/TNFRSF8
Quantity
100 μg
Gene ID (Entrez)
943
Target Species
Human
Form
Supernatant
Related Products
Description
- CD30/TNFRSF8 Monoclonal specifically detects CD30/TNFRSF8 in Human samples
- It is validated for Flow Cytometry.